Globe Newswire
CHANDLER, Ariz., May 01, 2024 (GLOBE NEWSWIRE) -- Developers of spacecraft electronics utilize radiation-tolerant (RT) field programmable gate arrays (FPGAs) to ensure high performance, reliability, power-efficiency and the best-in-class security for emerging space domain threats. To take it a step further and help provide fast, cost-effective software customization, Microchip Technology (Nasdaq: MCHP) has introduced the RT PolarFire® system-on-chip (SoC) FPGA.... (continue reading...)
TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- on|comms has chosen Optiva (TSX: OPT) BSS platform, hosted on Google Cloud, to provide mobile connectivity to its members with the launch of a new MVNO service. on|comms will provide simplified access to a wide variety of veterans services and a comprehensive transition assistance program supporting active duty service members and their families and their reintegration into civilian life.
on|comms is the connectivity partner... (continue reading...)
– Josh Rosen to shed Interim title and become Chief Executive Officer; Company provides other key personnel updates –
– Company receives a short-term extension of the maturity date on its credit facility –
– Company plans corporate name change to Vireo –
MINNEAPOLIS, May 01, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. (“Goodness Growth” or the “Company”) (CSE: GDNS; OTCQX: GDNSF), today announced several leadership and corporate... (continue reading...)
Company Striving Towards Near-Term Profitability Following Go-to-Market Approach Revamp and Cost Reduction Initiatives
New Pay-Per-Click SEO Pricing Model Gaining Strong Traction in Multiple Market Sectors
Streamlined Operations Results in Record Quarterly Gross Margin of 83.6%
PERTH, Australia, May 01, 2024 (GLOBE NEWSWIRE) -- Locafy Limited (Nasdaq: LCFY, LCFYW) (“Locafy” or the “Company”), a globally recognized software-as-a-service technology company... (continue reading...)
SAN DIEGO and RESEARCH TRIANGLE PARK, N.C. and SEATTLE, May 01, 2024 (GLOBE NEWSWIRE) -- Creyon Bio, Inc. ("Creyon"), a drug development company that engineers Oligonucleotide-Based Medicines (OBMs) with industry leading efficiency creating novel, best-in-class gene-centric medicines to treat rare and common diseases, and Cajal Neuroscience, ("Cajal"), a biotechnology company integrating disease-focused genetics and human data with state-of-the-art experimental... (continue reading...)
More Globe Newswire
View Older Stories-
Goodness Growth Provides CREAM & Fire Updates
-
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
-
Conduent Reports First Quarter 2024 Financial Results
-
Recursion to Participate in Upcoming Investor Conferences
-
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
-
Carpenter Technology Reports Third Quarter Fiscal Year 2024 Results
-
Capital Power announces first quarter 2024 results
-
Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer and Chief Business Officer
-
AltruBio to Participate in Upcoming May 2024 Medical Conferences
-
Century Aluminum Company Reports First Quarter 2024 Results
-
ImmuneSensor Therapeutics Appoints Veteran Biopharma Executive, Thomas W. Dubensky, Jr., Ph.D., as Chief Executive Officer
-
Integer to Present at 2024 Bank of America Securities Healthcare Conference on May 14
-
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
-
SPAR Group Completes Acquisition of Minority Interest in Resource Plus
-
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024
-
NOAA and National Safe Boating Council Celebrate 25th Anniversary with Continued National Safe Boating Week Partnership
-
Touro University Nevada College of Osteopathic Medicine Teaches Living Anatomy and Physiology with Vave Health Pocket Ultrasound
-
Snyk Launches AppRisk Pro, Developer First Application Security Posture Management Solution Leveraging AI to Prioritize Remediation
-
Auron Announces Oral Presentation on Preclinical Data from Proprietary AURIGIN™ Platform at the AI in Biomedicine Keystone Symposia
-
The senior managemet team of All Universe visits the tobacco plantation base in Kelantan, Malaysia.
-
HYTN Welcomes U.S. Recommendation to Reclassify Cannabis, Foresees Growth
-
authID to Report First Quarter 2024 Financial Results on May 15, 2024
-
VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting
-
Clubhouse Media Group, Inc. Releases “Tik Tok-Like” Video Feature On HoneyDrip.com
-
Canadian motorists understand proper tire inflation improves fuel economy and optimizes electric vehicle range as they navigate higher cost of living: survey
-
Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum
-
LGI Homes Offers First Built Green Certified Homes in Tacoma, Washington
-
Primech Holdings Limited Engages Strategic Investor Relations to Enhance Investor Communications and Engagement
-
New YPrime Report Highlights eCOA's Impact on CNS Trials
-
Lightbridge to Hold Business Update & First Quarter 2024 Earnings Conference Call on Friday, May 10th at 11 a.m. ET
-
TTM Technologies, Inc. Reports First Quarter 2024 Results
-
2024 Palmetto Heroes Program
-
WBS conducts monthly token burning, exploring the ecosystem layout and potential of Websea
-
VERSES Promotes Hari Thiruvengada PhD to Chief Product Officer
-
Precision Cleaning Specialist JE Cleantech Delivers Healthy Performance In 2023
-
Sunrun’s ‘PowerOn Puerto Rico’ Virtual Power Plant Helps Island Avoid Rolling Blackouts
-
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
-
BetterLife Advances BETR-001 IND-enabling Studies
-
TransUnion to Present at the 2024 Barclays Americas Select Franchise Conference
-
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
-
CTS Announces First Quarter 2024 Results
-
PharmaTher’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
-
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
-
Treatment.com AI Announces Contract Renewal with Leading US Medical School
-
Environics Analytics Brings LiveRamp Technology to Canada – Accelerating Data Collaboration, Audience Targeting, and Cross-Channel Measurement for Brands, Publishers, and Agencies
-
RunReveal Secures Funding to Redefine Security Information and Event Management (SIEM)
-
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
-
Inovalon Earns 2024 Great Place To Work® Certification™ For Second Consecutive Year
-
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
-
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8